Search Results - "Kalicanin, Nevena"

Heterologous Expression and Partial Characterization of a Putative Opine Dehydrogenase from a Metagenomic Sequence of Desulfohalobium retbaense by Kalicanin, Nevena, Balaz, Ana Marija, Prodanovic, Olivera, Prodanovic, Radivoje

“…The aim of this research was to prove the function of the putative opine dehydrogenase from Desulfohalobium retbaense and to characterize the enzyme in terms…”
Get full text

Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studies by Ferjancic, Zorana, Bihelovic, Filip, Vulovic, Bojan, Matovic, Radomir, Trmcic, Milena, Jankovic, Aleksandar, Pavlovic, Milos, Djurkovic, Filip, Prodanovic, Radivoje, Djurdjevic Djelmas, Aleksandra, Kalicanin, Nevena, Zlatovic, Mario, Sladic, Dusan, Vallet, Thomas, Vignuzzi, Marco, Saicic, Radomir N

“…We developed new iminosugar-based glycosidase inhibitors against SARS-CoV-2. Known drugs (miglustat, migalastat, miglitol, and swainsonine) were chosen as lead…”
Get full text

In Silico and In Vitro Inhibition of SARS-CoV-2 PLpro with Gramicidin D by Protić, Sara, Kaličanin, Nevena, Sencanski, Milan, Prodanović, Olivera, Milicevic, Jelena, Perovic, Vladimir, Paessler, Slobodan, Prodanović, Radivoje, Glisic, Sanja

“…Finding an effective drug to prevent or treat COVID-19 is of utmost importance in tcurrent pandemic. Since developing a new treatment takes a significant…”
Get full text

Immobilization of ArRMut11 omega-transaminase for increased operational stability and reusability in the synthesis of 3α-amino-5α-androstan-17β-ol by Kaličanin, Nevena, Kovačević, Gordana, Spasojević, Milica, Prodanović, Olivera, Jovanović-Šanta, Suzana, Škorić, Dušan, Opsenica, Dejan, Prodanović, Radivoje

“…The aim of this research was to improve the operational stability and enable the reusability of ω-transaminase for synthesis of new enantiopure chiral amines…”
Get full text

SARS‐CoV‐2 PLpro Inhibition: Evaluating in Silico Repurposed Fidaxomicin's Antiviral Activity Through In Vitro Assessment by Protić, Sara, Crnoglavac Popović, Milica, Kaličanin, Nevena, Prodanović, Olivera, Senćanski, Milan, Milićević, Jelena, Stevanović, Kristina, Perović, Vladimir, Paessler, Slobodan, Prodanović, Radivoje, Glišić, Sanja

“…The emergence of drug‐resistant viruses and novel strains necessitates the rapid development of novel antiviral therapies. This need was particularly demanding…”
Get full text

Inhibition of SARS-CoV-2 Mpro with Vitamin C, L-Arginine and a Vitamin C/L-Arginine Combination by Đukić, Ivana, Kaličanin, Nevena, Sencanski, Milan, Pajovic, Snezana B., Milicevic, Jelena, Prljic, Jelena, Paessler, Slobodan, Prodanović, Radivoje, Glisic, Sanja

“…BACKGROUNDDrug resistance is a critical problem in health care that affects therapy outcomes and requires new approaches to drug design. SARS-CoV-2 Mpro…”
Get full text

SARS-CoV-2 PL pro Inhibition: Evaluating in Silico Repurposed Fidaxomicin's Antiviral Activity Through In Vitro Assessment by Protić, Sara, Crnoglavac Popović, Milica, Kaličanin, Nevena, Prodanović, Olivera, Senćanski, Milan, Milićević, Jelena, Stevanović, Kristina, Perović, Vladimir, Paessler, Slobodan, Prodanović, Radivoje, Glišić, Sanja

“…The emergence of drug-resistant viruses and novel strains necessitates the rapid development of novel antiviral therapies. This need was particularly demanding…”
Get full text

In Silico and In Vitro Inhibition of SARS-CoV-2 PL pro with Gramicidin D by Protić, Sara, Kaličanin, Nevena, Sencanski, Milan, Prodanović, Olivera, Milicevic, Jelena, Perovic, Vladimir, Paessler, Slobodan, Prodanović, Radivoje, Glisic, Sanja

“…Finding an effective drug to prevent or treat COVID-19 is of utmost importance in tcurrent pandemic. Since developing a new treatment takes a significant…”
Get full text

Inhibition of SARS-CoV-2 M pro with Vitamin C, L-Arginine and a Vitamin C/L-Arginine Combination by Đukić, Ivana, Kaličanin, Nevena, Sencanski, Milan, Pajovic, Snezana B, Milicevic, Jelena, Prljic, Jelena, Paessler, Slobodan, Prodanović, Radivoje, Glisic, Sanja

“…Drug resistance is a critical problem in health care that affects therapy outcomes and requires new approaches to drug design. SARS-CoV-2 Mpro mutations are of…”
Get full text